The need for a national blood product monitoring system: role of hemophilia registries
- 1 July 1995
- journal article
- Published by Wiley in Transfusion
- Vol. 35 (7) , 540-541
- https://doi.org/10.1046/j.1537-2995.1995.35795357873.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The Canadian Hemophilia Registry as the basis for a national system for monitoring the use of factor concentratesTransfusion, 1995
- Viral Contamination of Blood Components and Approaches for Reduction of InfectivityImmunological Investigations, 1995
- Factor VIII preparations: need for prospective pharmacovigilanceThe Lancet, 1993
- Effect of using safer blood products on prevalence of HIV infection in haemophilic Canadians. Canadian Hemophilia Clinic Directors Group.BMJ, 1993
- A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII ConcentrateThrombosis and Haemostasis, 1993
- Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85.BMJ, 1989